Susquehanna International Group, LLP Lexicon Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$1.54 - $2.28 $183,414 - $271,548	-119,100 Reduced 40.94%	171,800 $288,000
Q1 2024 May 07, 2024	BUY	$1.3 - $3.58 $171,730 - $472,918	132,100 Added 83.19%	290,900 $698,000
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $31,000 - $47,430	31,000 Added 24.26%	158,800 $242,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $59,360 - $130,480	-56,000 Reduced 30.47%	127,800 $139,000
Q2 2023 Aug 11, 2023	BUY	$2.15 - $3.49 $273,265 - $443,579	127,100 Added 224.16%	183,800 $420,000
Q1 2023 May 16, 2023	BUY	$1.99 - $2.68 $59,501 - $80,132	29,900 Added 111.57%	56,700 $137,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $8,100 - $11,520	4,500 Added 20.18%	26,800 $51,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $43,262 - $76,489	22,300 New	22,300 $54,000
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $85,995 - $171,549	-44,100 Reduced 70.56%	18,400 $38,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $147,828 - $239,008	38,800 Added 163.71%	62,500 $246,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $249,782 - $395,365	-73,900 Reduced 75.72%	23,700 $114,000
Q2 2021 Aug 11, 2021	SELL	$4.12 - $5.87 $65,096 - $92,746	-15,800 Reduced 13.93%	97,600 $448,000
Q1 2021 May 17, 2021	SELL	$3.45 - $9.09 $497,145 - $1.31 Million	-144,100 Reduced 55.96%	113,400 $666,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $204,855 - $716,017	195,100 Added 312.66%	257,500 $881,000
Q3 2020 Nov 16, 2020	BUY	$1.44 - $2.1 $31,824 - $46,410	22,100 Added 54.84%	62,400 $90,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.3 $26,775 - $35,190	15,300 Added 61.2%	40,300 $80,000
Q1 2020 May 15, 2020	SELL	$1.8 - $4.28 $170,820 - $406,172	-94,900 Reduced 79.15%	25,000 $49,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $100,804 - $164,285	31,900 Added 36.25%	119,900 $498,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $23,640 - $131,202	-19,700 Reduced 18.29%	88,000 $265,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $585,290 - $777,834	-109,400 Reduced 50.39%	107,700 $677,000
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $513,608 - $935,332	117,800 Added 118.63%	217,100 $1.21 Million
Q4 2018 Feb 14, 2019	SELL	$6.15 - $10.51 $513,525 - $877,585	-83,500 Reduced 45.68%	99,300 $659,000
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $722,400 - $914,200	70,000 Added 62.06%	182,800 $1.95 Million
Q2 2018 Aug 14, 2018	SELL	$7.8 - $13.69 $152,880 - $268,324	-19,600 Reduced 14.8%	112,800 $1.35 Million
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $419,724 - $608,226	53,400 Added 67.59%	132,400 $1.14 Million
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $1.79 Million - $2.51 Million	-204,000 Reduced 72.08%	79,000 $781,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $3.44 Million - $4.61 Million	283,000	283,000 $3.48 Million

Others Institutions Holding LXRX

# of Institutions

131

Shares Held

240M

Call Options Held

617K

Put Options Held

286K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $298M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account